Life expectancy and death from cardiomyopathy amongst carriers of Duchenne and Becker muscular dystrophy in Scotland

被引:31
|
作者
Holloway, S. M. [1 ]
Wilcox, D. E. [2 ]
Wilcox, A. [2 ]
Dean, J. C. S. [3 ]
Berg, J. N. [4 ]
Goudie, D. R. [4 ]
Denvir, M. A. [5 ]
Porteous, M. E. M. [1 ]
机构
[1] Western Gen Hosp, Dept Clin Genet, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Yorkhill Hosp, Ferguson Smith Ctr Clin Genet, Glasgow, Lanark, Scotland
[3] Clin Genet Ctr, Aberdeen, Scotland
[4] Ninewells Hosp, Dept Clin Genet, Dundee DD1 9SY, Scotland
[5] Western Gen Hosp, Dept Cardiol, Edinburgh EH4 2XU, Midlothian, Scotland
关键词
D O I
10.1136/hrt.2007.125948
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To assess life expectancy and cardiovascular mortality in carriers of Duchenne and Becker muscular dystrophy. Design: Family pedigrees of individuals affected with these conditions, held by the four genetics centres in Scotland, were examined to identify a cohort of definite carriers. Electronic death registration data, held by the General Register Office for Scotland, were used to identify death certificates of carriers who had died, to obtain age at death and cause of death. Survival and mortality data were obtained for the general population for comparison. Patients: 397 definite carriers in 202 pedigrees were identified from which 94 deaths were identified by record linkage to death certificates. Main outcome measures: Observed numbers surviving to certain ages and numbers dying of cardiac causes were compared with expected numbers calculated from general population data. Results: There were no significant differences between observed and expected numbers surviving to ages 40-90. The standardised mortality ratio for the 371 carriers alive in 1974 was 0.53 (95% confidence interval 0.32 to 0.82). Conclusions: Whereas female carriers may have clinical features of cardiomyopathy, this study does not suggest that this is associated with reduced life expectancy or increased risk of cardiac death. Routine cardiac surveillance of obligate carriers is therefore probably unnecessary.
引用
收藏
页码:633 / 636
页数:4
相关论文
共 50 条
  • [1] Duchenne and Becker muscular dystrophy carriers: emerging evidence for a clinically important cardiomyopathy
    Mah, M.
    Cripe, L.
    Al-Zaidy, S.
    Camino, E.
    Slawinski, M.
    Jackson, J.
    Mendell, J.
    Hor, K.
    [J]. NEUROMUSCULAR DISORDERS, 2018, 28 : S98 - S99
  • [2] Life expectancy and causes of death in patients with Duchenne muscular dystrophy
    Wahlgren, L.
    Kroksmark, A.
    Tulinius, M.
    Sofou, K.
    [J]. NEUROMUSCULAR DISORDERS, 2020, 30 : S146 - S146
  • [3] Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy
    Hoogerwaard, EM
    Ginjaar, IB
    Bakker, E
    de Visser, M
    [J]. NEUROLOGY, 2005, 65 (12) : 1984 - 1986
  • [4] Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy
    Hoogerwaard, EM
    van der Wouw, PA
    Wilde, AAM
    Bakker, E
    Ippel, PF
    Oosterwijk, JC
    Majoor-Krakauer, DF
    van Essen, AJ
    Leschot, NJ
    de Visser, M
    [J]. NEUROMUSCULAR DISORDERS, 1999, 9 (05) : 347 - 351
  • [5] Manifestations of Duchenne and Becker muscular dystrophy among carriers
    [J]. European Journal of Pediatrics, 1999, 158 : A946 - A946
  • [7] Duchenne and Becker muscular dystrophy carriers: Evidence of cardiomyopathy by exercise and cardiac MRI testing
    Mah, May Ling
    Cripe, Linda
    Slawinski, Michelle K.
    Al-Zaidy, Samiah A.
    Camino, Eric
    Lehman, Kelly J.
    Jackson, Jamie L.
    Iammarino, Megan
    Miller, Natalie
    Mendell, Jerry R.
    Hor, Kan N.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 316 : 257 - 265
  • [8] CMR Detects Subclinical Cardiomyopathy in Mother-Carriers of Duchenne and Becker Muscular Dystrophy
    Mavrogeni, Sophie
    Bratis, Konstantinos
    Papavasiliou, Antigoni
    Skouteli, Eleni
    Karanasios, Evangelos
    Georgakopoulos, Dimitris
    Kolovou, Genovefa
    Papadopoulos, George
    [J]. JACC-CARDIOVASCULAR IMAGING, 2013, 6 (04) : 526 - 528
  • [9] The natural history of the cardiomyopathy of Duchenne and Becker muscular dystrophy
    Nealon, E.
    Beckman, B.
    Kertesz, N.
    Cripe, L.
    [J]. NEUROMUSCULAR DISORDERS, 2020, 30 : S63 - S63
  • [10] Treatment with deflazacort and cardiomyopathy in Duchenne/Becker muscular dystrophy
    Politano, L
    Palladino, A
    Passamano, L
    Petretta, VR
    Comi, LI
    Nigro, G
    [J]. NEUROMUSCULAR DISORDERS, 2004, 14 (8-9) : 581 - 582